Institutional & Family Asset Management, LLC Gamida Cell Ltd. Transaction History

Institutional & Family Asset Management, LLC

  • $846 Million
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$0.85 - $1.87 $3,803 - $8,368
-4,475 Reduced 69.38%
1,975 $2,000
Q2 2023

Aug 09, 2023
SELL
$0.73 - $2.37 $463 - $1,504
-635 Reduced 8.96%
6,450 $12,000
Q4 2021

Feb 14, 2022
BUY
$2.2 - $4.46 $8,690 - $17,617
3,950 Added 126.0%
7,085 $18,000
Q1 2021

May 06, 2021
BUY
$7.8 - $12.43 $11,115 - $17,712
1,425 Added 83.33%
3,135 $25,000
Q4 2020

Feb 03, 2021
BUY
$4.07 - $11.0 $6,878 - $18,590
1,690 Added 8450.0%
1,710 $14,000
Q3 2020

Oct 30, 2020
BUY
$3.93 - $4.59 $78 - $91
20 New
20 $0

Others Institutions Holding GMDA

# of Institutions
1
Shares Held
2.2K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email